市場調査レポート

商品コード

1529719

炎症性腸疾患治療の市場規模・シェア・動向分析レポート：タイプ別、薬剤クラス別、投与経路別、流通経路別、地域別、セグメント予測、2024年～2030年

Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report By Type (Crohn's Disease, Ulcerative Colitis), By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

出版日: 2024年07月09日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日

カスタマイズ可能

価格

Unprintable PDF (Single User License)

USD 5,950 854,241円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 997,811円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,284,951円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

炎症性腸疾患治療市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の炎症性腸疾患治療市場規模は、2024年から2030年にかけてCAGR 3.8%で拡大し、2030年には277億3,000万米ドルに達する見込みです。

この疾患の有病率の増加、炎症性腸疾患に対する人々の意識の急増、有利な規制シナリオが、予測期間にわたって炎症性腸疾患治療市場を牽引すると予測されています。例えば、2022年12月、ファイザー社は、重度の潰瘍性大腸炎患者に対するエトラシモドの新薬承認申請が米国FDAに受理されたと発表しました。炎症性腸疾患の治療指定や新薬の承認に向けた規制当局の好意的な取り組みが、市場拡大に拍車をかけています。

IBD治療のための新規治療薬の開発における様々な課題に対抗するために、市場関係者と非営利団体との協力が増加していることは、市場の成長を促進すると予測されます。例えば、2022年10月、プレシジョンヘルス企業のVerilyとクローン病・大腸炎財団は、潰瘍性大腸炎とクローン病の研究を加速するために戦略的提携を拡大しました。さらに、欧州クローン病・大腸炎機構は、炎症性腸疾患患者のケアを改善するためにいくつかの好意的な措置を講じています。

炎症性腸疾患の治療薬として最近承認されたフィルゴチニブ、オザニモド、ウパダシチニブ、リサンキズマブなどの新薬は、今後数年間の市場成長を支えるものと期待されています。さらに、規制当局は、希少疾患や生命を脅かす疾患に対する新規治療アプローチの開発をメーカーに奨励しています。例えば、2020年12月、テティス・ファーマシューティカルズはTP-317の小児潰瘍性大腸炎に対するオーファンドラッグ指定を米国FDAから受けた。このような有利なイニシアチブは、IBDの新規治療製品を開発するための研究開発活動を後押しすると予想されます。

さらに、様々な炎症性疾患の治療に対するバイオシミラーの需要と承認の高まりは、市場にとってインパクトの大きいレンダリング要因です。例えば、2022年12月、米国FDAは8番目のアダリムマブ・バイオシミラーとしてIdacioを承認しました。新たに承認されたバイオシミラーは、成人および6歳以上の小児のCDを含む複数の炎症性疾患の治療を目的としたクエン酸塩フリーの低濃度製剤です。また、米国FDAは2021年10月、中等症から重症のCDおよびUCの治療薬としてサイルテゾを承認しました。さらに、バイオシミラーのイントロダクションの増加は、新興経済諸国におけるIBD治療のための生物学的製剤の採用を促進すると予想されます。

さらに、政府機関はバイオシミラーの安全な使用を促進するための取り組みを行っています。例えば、2022年10月、サスカチュワン州政府は、住民がより安価で高品質の治療薬を入手できるよう、バイオシミラー・イニシアチブを立ち上げました。同様に、カナダのオンタリオ州やケベック州なども、バイオシミラー候補の取り込みを促進するため、バイオシミラー・イニシアチブを拡大しています。

炎症性腸疾患市場レポートハイライト

クローン病分野は、有病率の増加と治療薬としての生物学的製剤の処方率の高さにより、最大シェアを占めています。
潰瘍性大腸炎分野は、潰瘍性大腸炎の治療に対する生物学的製剤の承認の高まりと患者数の多さから、最も速い成長率を記録する見込みです。
TNF阻害剤セグメントは、IBD治療に対する処方率の高さとTNF阻害剤に対する消費者の意識の高まりにより、2023年に最大の市場シェアを占めました。
投与経路別では、2023年に注射剤セグメントが炎症性腸疾患治療薬市場を独占したが、経口剤セグメントが最も急成長すると予測されます。
2023年には、入院率の上昇と有利な償還適用により、病院薬局セグメントが最大となった。
アジア太平洋地域は、市場参入企業による投資の増加と同地域における疾患有病率の増加により、予測期間中に最も速い成長率を示すと予想されます。

炎症性腸疾患治療市場シェア、地域別、2023年および2030年
北米
- 北米の炎症性腸疾患治療市場推計・予測、2018年-2030年
- 米国
- カナダ
欧州
- 欧州の炎症性腸疾患治療市場推計・予測、2018年-2030年
- ドイツ
- 英国
- スペイン
- フランス
- イタリア
- デンマーク
- スウェーデン
- ノルウェー
アジア太平洋
- アジア太平洋地域の炎症性腸疾患治療市場推計・予測、2018年-2030年
- 日本
- 中国
- インド
- 韓国
- オーストラリア
- シンガポール
- タイ
ラテンアメリカ
- ラテンアメリカの炎症性腸疾患治療市場推計・予測、2018年-2030年
- ブラジル
- メキシコ
- アルゼンチン
中東およびアフリカ
- 中東およびアフリカの炎症性腸疾患治療市場推計・予測、2018年-2030年
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第9章競合情勢

主要市場参入企業による最近の動向と影響分析
企業分類
企業市場シェア分析、2023年
戦略マッピング
- 拡大
- 合併と買収
- パートナーシップとコラボレーション
- 新製品の発売
- 研究開発
企業プロファイル
- AbbVie Inc.
- Takeda Pharmaceutical Company Limited
- Pfizer Inc.
- Biogen
- Novartis AG
- Lilly
- UCB SA
- CELLTRION INC.
- Merck &Co., Inc.
- Johnson &Johnson Services, Inc

図表

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 Global Inflammatory Bowel Disease Treatment Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 6 Global Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 7 Global Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 8 Global Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 9 North America Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 10 North America Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 11 North America Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 12 North America Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 13 North America Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 14 U.S. Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 15 U.S. Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 16 U.S. Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 17 U.S. Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 18 Canada Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 19 Canada Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 20 Canada Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 21 Canada Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 22 Europe Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 23 Europe Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 24 Europe Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 25 Europe Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 26 Europe Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 27 Germany Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 28 Germany Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 29 Germany Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 30 Germany Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 31 UK Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 32 UK Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 33 UK Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 34 UK Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 35 France Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 36 France Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 37 France Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 38 France Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 39 Italy Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 40 Italy Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 41 Italy Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 42 Italy Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 43 Spain Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 44 Spain Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 45 Spain Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 46 Spain Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 47 Denmark Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 48 Denmark Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 49 Denmark Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 50 Denmark Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 51 Sweden Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 52 Sweden Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 53 Sweden Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 54 Sweden Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 55 Norway Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 56 Norway Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 57 Norway Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 58 Norway Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 63 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 64 Japan Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 65 Japan Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 66 Japan Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 67 Japan Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 68 China Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 69 China Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 70 China Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 71 China Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 72 India Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 73 India Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 74 India Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 75 India Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 76 South Korea Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 77 South Korea Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 78 South Korea Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 79 South Korea Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 80 Australia Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 81 Australia Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 82 Australia Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 83 Australia Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 84 Singapore Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 85 Singapore Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 86 Singapore Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 87 Singapore Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 88 Thailand Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 89 Thailand Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 90 Thailand Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 91 Thailand Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 92 Latin America Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 93 Latin America Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 94 Latin America Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 95 Latin America Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 96 Latin America Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 97 Mexico Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 98 Mexico Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 99 Mexico Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 100 Mexico Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 101 Brazil Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 102 Brazil Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 103 Brazil Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 104 Brazil Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 105 Argentina Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 106 Argentina Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 107 Argentina Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 108 Argentina Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 109 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 110 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 111 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 112 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 113 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 114 South Africa Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 115 South Africa Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 116 South Africa Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 117 South Africa Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 118 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 119 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 120 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 121 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 122 UAE Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 123 UAE Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 124 UAE Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 125 UAE Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 126 Kuwait Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 127 Kuwait Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 128 Kuwait Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 129 Kuwait Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Inflammatory bowel disease treatment market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2023)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter's five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Inflammatory bowel disease treatment market: Type movement analysis
Fig. 17 Inflammatory bowel disease treatment market: Type segment dashboard
Fig. 18 Inflammatory bowel disease treatment market Type outlook: Key takeaways
Fig. 19 Crohn's disease market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Ulcerative Colitis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Inflammatory bowel disease treatment market: Drug class movement analysis
Fig. 22 Inflammatory bowel disease treatment market: Drug class segment dashboard
Fig. 23 Inflammatory bowel disease treatment market Drug class outlook: Key takeaways
Fig. 24 Aminosalicylates market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 TNF inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 IL inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Anti-integrin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 JAK inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Inflammatory bowel disease treatment market: Route of administration movement analysis
Fig. 32 Inflammatory bowel disease treatment market: Route of administration segment dashboard
Fig. 33 Inflammatory bowel disease treatment market Route of administration outlook: Key takeaways
Fig. 34 Oral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Inflammatory bowel disease treatment market: Distribution channel movement analysis
Fig. 37 Inflammatory bowel disease treatment market: Distribution channel segment dashboard
Fig. 38 Inflammatory bowel disease treatment market Distribution channel outlook: Key takeaways
Fig. 39 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Online pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Regional outlook, 2023 & 2030
Fig. 43 Regional market dashboard
Fig. 44 Regional market place: Key takeaways
Fig. 45 North America, SWOT
Fig. 46 Europe, SWOT
Fig. 47 Asia Pacific, SWOT
Fig. 48 Latin America, SWOT
Fig. 49 Middle East and Africa, SWOT
Fig. 50 North America
Fig. 51 North America inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 52 U.S.
Fig. 53 U.S. inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 54 Canada
Fig. 55 Canada inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 56 Europe
Fig. 57 Europe inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 58 UK
Fig. 59 UK inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 60 Germany
Fig. 61 Germany inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 62 Spain
Fig. 63 Spain inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 64 France
Fig. 65 France inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 66 Italy
Fig. 67 Italy inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 68 Denmark
Fig. 69 Denmark inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 70 Norway
Fig. 71 Norway inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 72 Sweden
Fig. 73 Sweden inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 74 Asia Pacific
Fig. 75 Asia Pacific inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 76 Japan
Fig. 77 Japan inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 78 China
Fig. 79 China inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 80 India
Fig. 81 India inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 82 South Korea
Fig. 83 South Korea inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 84 Australia
Fig. 85 Australia inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 86 Singapore
Fig. 87 Singapore inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 88 Thailand
Fig. 89 Thailand inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 90 Latin America
Fig. 91 Latin America inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 92 Brazil
Fig. 93 Brazil inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 94 Mexico
Fig. 95 Mexico inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 96 Argentina
Fig. 97 Argentina inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 98 Middle East and Africa
Fig. 99 MEA inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 100 South Africa
Fig. 101 South Africa inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 102 Saudi Arabia
Fig. 103 Saudi Arabia inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 104 UAE
Fig. 105 UAE inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 106 Kuwait
Fig. 107 Kuwait inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 108 Ansoff Matrix
Fig. 109 Heat map analysis
Fig. 110 Market differentiators

Product Code: GVR-3-68038-114-6

Inflammatory Bowel Disease Treatment Market Growth & Trends:

The global inflammatory bowel disease treatment market size is expected to reach USD 27.73 billion by 2030, expanding at a CAGR of 3.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of the disease, the surge in awareness about inflammatory bowel disease among people, and favorable regulatory scenarios are projected to drive the inflammatory bowel disease treatment market over the forecast period. For instance, in December 2022, Pfizer Inc. announced the U.S. FDA acceptance for review of an NDA for etrasimod for patients having severe ulcerative colitis. The favorable initiatives undertaken by regulatory authorities for treatment designations and approval of novel drugs for the management of inflammatory bowel disease are fueling market expansion.

The increasing collaboration of market players and non-profit organizations to counter various challenges in the development of novel therapeutics for IBD treatment is projected to propel market growth. For instance, in October 2022, Verily, a precision health company and the Crohn's & Colitis Foundation expanded their strategic collaboration to accelerate research in ulcerative colitis and Crohn's disease. In addition, the European Crohn's and Colitis Organization has taken several favorable steps to improve the care of patients living with inflammatory bowel disease.

Recently approved novel drugs such as filgotinib, ozanimod, upadacitinib, and risankizumab for the treatment of inflammatory bowel disease are expected to support market growth in the coming years. Moreover, the regulatory authorities are encouraging manufacturers to develop novel therapeutic approaches for rare and life-threatening diseases. For instance, in December 2020, Thetis Pharmaceuticals received an orphan drug designation for TP-317 from the U.S. FDA for pediatric ulcerative colitis. Such favorable initiatives are expected to boost the R&D activities to develop novel therapeutic products for IBD.

Furthermore, the rising demand & approvals for biosimilars for the treatment of various inflammatory conditions is a high-impact rendering factor for the market. For instance, in December 2022, the U.S. FDA approved Idacio as an eighth adalimumab biosimilar in the U.S. The newly approved biosimilar is a citrate-free low-concentration preparation intended for the treatment of several inflammatory conditions, including CD in adults and children aged 6 years or older. In addition, in October 2021, the U.S. FDA approved Cyltezo for the management of moderate to severe CD and UC. Moreover, the increasing introduction of biosimilars is expected to boost the adoption of biological products for the treatment of IBD in developing economies.

Moreover, government bodies are taking efforts to promote the uptake of biosimilars with their safe use. For instance, in October 2022, the government of Saskatchewan launched a biosimilar initiative to help its residents to access high-quality therapeutics at a lesser cost. Similarly, provinces like Ontario and Quebec in Canada are also expanding biosimilar initiatives to promote the uptake of biosimilar candidates.

Inflammatory Bowel Disease Market Report Highlights:

The Crohn's disease segment held the largest share owing to the increasing prevalence of the condition and the high prescription rate of biologics for the treatment of the disease
The ulcerative colitis segment is poised to register the fastest growth rate due to the rising approval of biologics for the treatment of ulcerative colitis and the high patient base
The TNF inhibitors segment accounted for the largest market share in 2023 owing to the high prescription rate for the treatment of IBD and rising consumer awareness about TNF inhibitors
Based on the route of administration, the injectable segment dominated the inflammatory bowel disease treatment market in 2023, whereas the oral segment is anticipated to be the fastest-growing segment
The hospital pharmacy segment was the largest in 2023, owing to higher hospitalization rates and favorable reimbursement coverage
Asia Pacific is expected to exhibit the fastest growth rate over the forecast period due to the rising investments by market players and increasing disease prevalence in the region

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
- 1.2.1. Type
- 1.2.2. Drug Class
- 1.2.3. Route of Administration
- 1.2.4. Distribution Channel
1.3. Regional Scope
1.4. Estimates and Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
1.7. Details of primary research
1.8. Market Formulation & Validation
1.9. Model Details
- 1.9.1. Commodity flow analysis (Model 1)
  - 1.9.1.1. Approach 1: Commodity flow approach
- 1.9.2. Volume price analysis (Model 2)
  - 1.9.2.1. Approach 2: Volume price analysis
1.10. Research Scope and Assumptions
- 1.10.1. List of Secondary Sources
- 1.10.2. List of Primary Sources
- 1.10.3. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Inflammatory Bowel Disease Treatment Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Drivers Analysis
  - 3.2.1.1. Robust product pipeline
  - 3.2.1.2. High prevalence of Crohn's disease and ulcerative colitis
  - 3.2.1.3. Increasing geriatric population
  - 3.2.1.4. Emergence of biosimilars
  - 3.2.1.5. Support of regulatory bodies for funding and designation
- 3.2.2. Market Restraints Analysis
  - 3.2.2.1. High cost of treatment
  - 3.2.2.2. Lack of early diagnosis
3.3. Inflammatory Bowel Disease Treatment Market Analysis Tools
- 3.3.1. Porter's Analysis
  - 3.3.1.1. Bargaining power of the suppliers
  - 3.3.1.2. Bargaining power of the buyers
  - 3.3.1.3. Threats of substitution
  - 3.3.1.4. Threats from new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Economic and Social landscape
  - 3.3.2.3. Technological landscape
  - 3.3.2.4. Legal landscape
3.4. List of Main Products & Average Selling Price

Chapter 4. Inflammatory Bowel Disease Treatment Market: Type Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Inflammatory Bowel Disease Treatment Market: Type Movement Analysis, USD Billion, 2023 & 2030
4.3. Crohn's Disease
- 4.3.1. Crohn's Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4. Ulcerative Colitis
- 4.4.1. Ulcerative Colitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Inflammatory Bowel Disease Treatment Market: Drug Class Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Inflammatory Bowel Disease Treatment Market: Drug Class Movement Analysis, USD Billion, 2023 & 2030
5.3. Aminosalicylates
- 5.3.1. Aminosalicylates Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.4. Corticosteroids
- 5.4.1. Corticosteroids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.5. TNF Inhibitors
- 5.5.1. TNF Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.6. IL Inhibitors
- 5.6.1. IL Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.7. Anti-integrin
- 5.7.1. Anti-integrin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.8. JAK Inhibitors
- 5.8.1. JAK Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.9. Others
- 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Inflammatory Bowel Disease Treatment Market: Route of Administration Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Inflammatory Bowel Disease Treatment Market: Route of Administration Movement Analysis, USD Billion, 2023 & 2030
6.3. Oral
- 6.3.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4. Injectable
- 6.4.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Inflammatory Bowel Disease Treatment Market: Distribution Channel Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Inflammatory Bowel Disease Treatment Market: Distribution Channel Movement Analysis, USD Billion, 2023 & 2030
7.3. Hospital Pharmacy
- 7.3.1. Hospital Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4. Retail Pharmacy
- 7.4.1. Retail Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.5. Online Pharmacy
- 7.5.1. Online Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Inflammatory Bowel Disease Treatment Market: Regional Estimates & Trend Analysis

8.1. Inflammatory Bowel Disease Treatment Market Share, By Region, 2023 & 2030, USD Billion
8.2. North America
- 8.2.1. North America Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.2.2. U.S.
  - 8.2.2.1. Key Country Dynamics
  - 8.2.2.2. Regulatory Landscape/Reimbursement Scenario
  - 8.2.2.3. Competitive Insights
  - 8.2.2.4. U.S. Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.2.3. Canada
  - 8.2.3.1. Key Country Dynamics
  - 8.2.3.2. Regulatory Landscape/Reimbursement Scenario
  - 8.2.3.3. Competitive Insights
  - 8.2.3.4. Canada Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3. Europe
- 8.3.1. Europe Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.2. Germany
  - 8.3.2.1. Key Country Dynamics
  - 8.3.2.2. Regulatory Landscape/Reimbursement Scenario
  - 8.3.2.3. Competitive Insights
  - 8.3.2.4. Germany Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.3. UK
  - 8.3.3.1. Key Country Dynamics
  - 8.3.3.2. Regulatory Landscape/Reimbursement Scenario
  - 8.3.3.3. Competitive Insights
  - 8.3.3.4. UK Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.4. Spain
  - 8.3.4.1. Key Country Dynamics
  - 8.3.4.2. Regulatory Landscape/Reimbursement Scenario
  - 8.3.4.3. Competitive Insights
  - 8.3.4.4. Spain Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.5. France
  - 8.3.5.1. Key Country Dynamics
  - 8.3.5.2. Regulatory Landscape/Reimbursement Scenario
  - 8.3.5.3. Competitive Insights
  - 8.3.5.4. France Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.6. Italy
  - 8.3.6.1. Key Country Dynamics
  - 8.3.6.2. Regulatory Landscape/Reimbursement Scenario
  - 8.3.6.3. Competitive Insights
  - 8.3.6.4. Italy Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.7. Denmark
  - 8.3.7.1. Key Country Dynamics
  - 8.3.7.2. Regulatory Landscape/Reimbursement Scenario
  - 8.3.7.3. Competitive Insights
  - 8.3.7.4. Denmark Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.8. Sweden
  - 8.3.8.1. Key Country Dynamics
  - 8.3.8.2. Regulatory Landscape/Reimbursement Scenario
  - 8.3.8.3. Competitive Insights
  - 8.3.8.4. Sweden Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.9. Norway
  - 8.3.9.1. Key Country Dynamics
  - 8.3.9.2. Regulatory Landscape/Reimbursement Scenario
  - 8.3.9.3. Competitive Insights
  - 8.3.9.4. Norway Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4. Asia Pacific
- 8.4.1. Asia Pacific Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.2. Japan
  - 8.4.2.1. Key Country Dynamics
  - 8.4.2.2. Regulatory Landscape/Reimbursement Scenario
  - 8.4.2.3. Competitive Insights
  - 8.4.2.4. Japan Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.3. China
  - 8.4.3.1. Key Country Dynamics
  - 8.4.3.2. Regulatory Landscape/Reimbursement Scenario
  - 8.4.3.3. Competitive Insights
  - 8.4.3.4. China Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.4. India
  - 8.4.4.1. Key Country Dynamics
  - 8.4.4.2. Regulatory Landscape/Reimbursement Scenario
  - 8.4.4.3. Competitive Insights
  - 8.4.4.4. India Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.5. South Korea
  - 8.4.5.1. Key Country Dynamics
  - 8.4.5.2. Regulatory Landscape/Reimbursement Scenario
  - 8.4.5.3. Competitive Insights
  - 8.4.5.4. South Korea Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.6. Australia
  - 8.4.6.1. Key Country Dynamics
  - 8.4.6.2. Regulatory Landscape/Reimbursement Scenario
  - 8.4.6.3. Competitive Insights
  - 8.4.6.4. Australia Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.7. Singapore
  - 8.4.7.1. Key Country Dynamics
  - 8.4.7.2. Regulatory Landscape/Reimbursement Scenario
  - 8.4.7.3. Competitive Insights
  - 8.4.7.4. Singapore Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.8. Thailand
  - 8.4.8.1. Key Country Dynamics
  - 8.4.8.2. Regulatory Landscape/Reimbursement Scenario
  - 8.4.8.3. Competitive Insights
  - 8.4.8.4. Thailand Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.5. Latin America
- 8.5.1. Latin America Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.5.2. Brazil
  - 8.5.2.1. Key Country Dynamics
  - 8.5.2.2. Regulatory Landscape/Reimbursement Scenario
  - 8.5.2.3. Competitive Insights
  - 8.5.2.4. Brazil Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.5.3. Mexico
  - 8.5.3.1. Key Country Dynamics
  - 8.5.3.2. Regulatory Landscape/Reimbursement Scenario
  - 8.5.3.3. Competitive Insights
  - 8.5.3.4. Mexico Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.5.4. Argentina
  - 8.5.4.1. Key Country Dynamics
  - 8.5.4.2. Regulatory Landscape/Reimbursement Scenario
  - 8.5.4.3. Competitive Insights
  - 8.5.4.4. Argentina Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6. Middle East and Africa
- 8.6.1. Middle East and Africa Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.6.2. South Africa
  - 8.6.2.1. Key Country Dynamics
  - 8.6.2.2. Regulatory Landscape/Reimbursement Scenario
  - 8.6.2.3. Competitive Insights
  - 8.6.2.4. South Africa Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.6.3. Saudi Arabia
  - 8.6.3.1. Key Country Dynamics
  - 8.6.3.2. Regulatory Landscape/Reimbursement Scenario
  - 8.6.3.3. Competitive Insights
  - 8.6.3.4. Saudi Arabia Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.6.4. UAE
  - 8.6.4.1. Key Country Dynamics
  - 8.6.4.2. Regulatory Landscape/Reimbursement Scenario
  - 8.6.4.3. Competitive Insights
  - 8.6.4.4. UAE Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.6.5. Kuwait
  - 8.6.5.1. Key Country Dynamics
  - 8.6.5.2. Regulatory Landscape/Reimbursement Scenario
  - 8.6.5.3. Competitive Insights
  - 8.6.5.4. Kuwait Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Market Share Analysis, 2023
9.4. Strategy Mapping
- 9.4.1. Expansion
- 9.4.2. Mergers & Acquisition
- 9.4.3. Partnerships & Collaborations
- 9.4.4. New Product Launches
- 9.4.5. Research And Development
9.5. Company Profiles
- 9.5.1. AbbVie Inc.
  - 9.5.1.1. Participant's Overview
  - 9.5.1.2. Financial Performance
  - 9.5.1.3. Product Benchmarking
  - 9.5.1.4. Recent Developments
- 9.5.2. Takeda Pharmaceutical Company Limited
  - 9.5.2.1. Participant's Overview
  - 9.5.2.2. Financial Performance
  - 9.5.2.3. Product Benchmarking
  - 9.5.2.4. Recent Developments
- 9.5.3. Pfizer Inc.
  - 9.5.3.1. Participant's Overview
  - 9.5.3.2. Financial Performance
  - 9.5.3.3. Product Benchmarking
  - 9.5.3.4. Recent Developments
- 9.5.4. Biogen
  - 9.5.4.1. Participant's Overview
  - 9.5.4.2. Financial Performance
  - 9.5.4.3. Product Benchmarking
  - 9.5.4.4. Recent Developments
- 9.5.5. Novartis AG
  - 9.5.5.1. Participant's Overview
  - 9.5.5.2. Financial Performance
  - 9.5.5.3. Product Benchmarking
  - 9.5.5.4. Recent Developments
- 9.5.6. Lilly
  - 9.5.6.1. Participant's Overview
  - 9.5.6.2. Financial Performance
  - 9.5.6.3. Product Benchmarking
  - 9.5.6.4. Recent Developments
- 9.5.7. UCB S.A.
  - 9.5.7.1. Participant's Overview
  - 9.5.7.2. Financial Performance
  - 9.5.7.3. Product Benchmarking
  - 9.5.7.4. Recent Developments
- 9.5.8. CELLTRION INC.
  - 9.5.8.1. Participant's Overview
  - 9.5.8.2. Financial Performance
  - 9.5.8.3. Product Benchmarking
  - 9.5.8.4. Recent Developments
- 9.5.9. Merck & Co., Inc.
  - 9.5.9.1. Participant's Overview
  - 9.5.9.2. Financial Performance
  - 9.5.9.3. Product Benchmarking
  - 9.5.9.4. Recent Developments
- 9.5.10. Johnson & Johnson Services, Inc
  - 9.5.10.1. Participant's Overview
  - 9.5.10.2. Financial Performance
  - 9.5.10.3. Product Benchmarking
  - 9.5.10.4. Recent Developments

炎症性腸疾患治療の市場規模・シェア・動向分析レポート：タイプ別、薬剤クラス別、投与経路別、流通経路別、地域別、セグメント予測、2024年～2030年

Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report By Type (Crohn's Disease, Ulcerative Colitis), By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

炎症性腸疾患治療市場の成長と動向：

炎症性腸疾患市場レポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章炎症性腸疾患治療市場の変数、動向、範囲

第4章炎症性腸疾患治療市場：タイプ別推定・動向分析

第5章炎症性腸疾患治療市場：薬剤クラス別推定・動向分析

第6章炎症性腸疾患治療市場：投与経路別推定・動向分析

第7章炎症性腸疾患治療市場：流通チャネル別推定・動向分析

第8章炎症性腸疾患治療市場：地域別推定・動向分析

第9章競合情勢

List of Tables

List of Figures

Inflammatory Bowel Disease Treatment Market Growth & Trends:

Inflammatory Bowel Disease Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Inflammatory Bowel Disease Treatment Market Variables, Trends, & Scope

Chapter 4. Inflammatory Bowel Disease Treatment Market: Type Estimates & Trend Analysis

Chapter 5. Inflammatory Bowel Disease Treatment Market: Drug Class Estimates & Trend Analysis

Chapter 6. Inflammatory Bowel Disease Treatment Market: Route of Administration Estimates & Trend Analysis

Chapter 7. Inflammatory Bowel Disease Treatment Market: Distribution Channel Estimates & Trend Analysis

Chapter 8. Inflammatory Bowel Disease Treatment Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

炎症性腸疾患治療の市場規模・シェア・動向分析レポート：タイプ別、薬剤クラス別、投与経路別、流通経路別、地域別、セグメント予測、2024年～2030年

Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report By Type (Crohn's Disease, Ulcerative Colitis), By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

炎症性腸疾患治療市場の成長と動向：

炎症性腸疾患市場レポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 炎症性腸疾患治療市場の変数、動向、範囲

第4章 炎症性腸疾患治療市場：タイプ別推定・動向分析

第5章 炎症性腸疾患治療市場：薬剤クラス別推定・動向分析

第6章 炎症性腸疾患治療市場：投与経路別推定・動向分析

第7章 炎症性腸疾患治療市場：流通チャネル別推定・動向分析

第8章 炎症性腸疾患治療市場：地域別推定・動向分析

第9章 競合情勢

List of Tables

List of Figures

Inflammatory Bowel Disease Treatment Market Growth & Trends:

Inflammatory Bowel Disease Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Inflammatory Bowel Disease Treatment Market Variables, Trends, & Scope

Chapter 4. Inflammatory Bowel Disease Treatment Market: Type Estimates & Trend Analysis

Chapter 5. Inflammatory Bowel Disease Treatment Market: Drug Class Estimates & Trend Analysis

Chapter 6. Inflammatory Bowel Disease Treatment Market: Route of Administration Estimates & Trend Analysis

Chapter 7. Inflammatory Bowel Disease Treatment Market: Distribution Channel Estimates & Trend Analysis

Chapter 8. Inflammatory Bowel Disease Treatment Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章炎症性腸疾患治療市場の変数、動向、範囲

第4章炎症性腸疾患治療市場：タイプ別推定・動向分析

第5章炎症性腸疾患治療市場：薬剤クラス別推定・動向分析

第6章炎症性腸疾患治療市場：投与経路別推定・動向分析

第7章炎症性腸疾患治療市場：流通チャネル別推定・動向分析

第8章炎症性腸疾患治療市場：地域別推定・動向分析

第9章競合情勢